Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Assessing reporting completeness and characteristics in decentralized randomized controlled trials: a scoping review
Juntao Wang1, Shuhui Li1, Chen Zhao2
1School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.
Background:
With the development of remote technology, decentralized clinical trials have rapidly increased in recent years. Despite the comprehensive reporting guidance provided by the CONSORT 2025 guideline, decentralized randomized controlled trials still face specific reporting challenges. Therefore, we aim to evaluate the reporting characteristics and completeness of decentralized randomized controlled trials, using a specially designed checklist that has been extended according to the CONSORT 2025 original items.
Methods:
We will search six databases (Embase, Ovid MEDLINE®, PubMed, CNKI, VIP, Wanfang) for decentralized randomized controlled trials published in Chinese or English during 2023. A pre-designed form will be used to extract general characteristics. Reporting completeness will be assessed using a custom 26-item "CONSORT-DRCT" checklist. This checklist includes 17 items focused on design, implementation, quality control, and key technologies related to decentralized elements, while 9 items pertain specifically to intervention details (5 for pharmacological interventions and 4 for non-pharmacological interventions). To ensure consistency, a standard operating procedure for scoring reporting completeness will be developed. Each item will be evaluated independently by two reviewers, and inter-rater agreement will be calculated to assess consistency between reviewers. Data will undergo descriptive analysis, with subgroup analyses performed where applicable to explore factors influencing reporting completeness.
Discussion:
This protocol outlines a methodological framework for conducting the review, which aims to identify the current reporting characteristics and completeness of decentralized randomized controlled trials. The results may offer valuable insights into the development of a CONSORT extension guideline for decentralized randomized controlled trials.
Systematic Review Registration:
This study has been registered with the Open Science Framework ( https://osf.io/c9pdx/ ).
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
04:04Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
Published on: July 11, 2025
Related Concept Videos
Randomized Experiments
Simple randomization
Simple...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Blinding